sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
1-May-2016 23:47
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 601-625 out of 1221.

<< < 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 > >>

Public Release: 14-May-2015
PLOS Pathogens
Bacteria contribute to immune suppression in skin after repeated schistosome exposure
Our two square meters of skin act as a defensive barrier against environmental pathogens but is also covered by beneficial commensal bacteria. A study published on May 14th in PLOS Pathogens explores this delicate balance and reports that when schistosome parasites repeatedly penetrate the skin they are cloaked in skin bacteria, leading to a tightly controlled and limited immune response, due in part to this cloaking mechanism.

Contact: Adrian Mountford

Public Release: 13-May-2015
Diabetes Technology & Therapeutics
Cybersecurity and the artificial pancreas -- what are the risks?
An artificial pancreas, designed for blood glucose control in diabetes, is controlled by software that runs on mobile computing platforms such as laptops, tablets, and smartphones, and operates over wireless networks under local or remote medical supervision.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 13-May-2015
Journal of Clinical Microbiology
New test could identify resistant tuberculosis faster
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
European Union's Seventh Framework Programme

Contact: Harry Dayantis
University College London

Public Release: 13-May-2015
TB Alliance launches 'Nix-TB' clinical trial to test new XDR-TB treatment
TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis. It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB.

Contact: Preeti Singh

Public Release: 12-May-2015
Malaria Journal
Malaria testing yet to reach its potential
In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.

Contact: Emily White Johansson
Uppsala University

Public Release: 12-May-2015
HIV Medicine
Gender difference in vital cell count of HIV patients
Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research from the University of Southampton.

Contact: Steven Williams
University of Southampton

Public Release: 12-May-2015
PLOS Medicine
Many fixed-dose drug combinations in India lack central regulatory approval
Fixed-dose drug combinations which have not received central regulatory approval are sold in substantial numbers in India -- despite concerns over the safety and efficacy of these combinations -- according to new research led by Queen Mary University of London and published in PLOS Medicine.

Contact: Charli Scouller
Queen Mary University of London

Public Release: 11-May-2015
Nature Medicine
Starved T cells allow hepatitis B to silently infect liver
Hepatitis B stimulates processes that deprive the body's immune cells of key nutrients that they need to function, finds new UCL-led research funded by the Medical Research Council and Wellcome Trust. The work helps to explain why the immune system cannot control hepatitis B virus infection once it becomes established in the liver, and offers a target for potential curative treatments down the line.
Medical Research Council, Wellcome Trust

Contact: Harry Dayantis
University College London

Public Release: 11-May-2015
PLOS Medicine
Global health leaders call for global biomedical R&D fund and mechanism
In advance of this month's World Health Assembly and the G7 summit in June, world leaders should consider the establishment of a global biomedical research and development fund and a mechanism to address the dearth in innovation for today's most pressing global health challenges, according to Bernard Pécoul, from the Drugs for Neglected Diseases Initiative, Geneva, Switzerland, and colleagues in an Essay published in this week's PLOS Medicine.

Contact: Hugh O' Brien

Public Release: 11-May-2015
Humans, livestock in Kenya linked in sickness and in health
After tracking 1,500 households and their livestock in 10 western Kenyan villages for one year, researchers found a strong relationship between the number of illnesses among family members and the number of livestock sicknesses and deaths in the same household.
Paul G. Allen School for Global Animal Health

Contact: Linda Weiford
Washington State University

Public Release: 11-May-2015
9th International Conference on Typhoid and invasive Non-Typhoidal Salmonelloses
Nature Genetics
Antibiotic-resistant typhoid detected in countries around the world
A landmark genomic study shows antibiotic-resistant typhoid is driven by a single family of the bacteria, called H58, that has now spread globally. The data describes one of the most comprehensive sets of genome data on a single human infectious agent. H58 clade of Typhi is displacing other typhoid strains, completely transforming the genetic architecture of the disease and creating a previously underappreciated and ongoing epidemic through countries in eastern and southern Africa.

Contact: Mary Clarke
Wellcome Trust Sanger Institute

Public Release: 10-May-2015
Proceedings of the National Academy of Sciences
Damming and damning hemorrhagic diseases
Rift Valley fever virus' proteins imitate human DNA repair factors, say University of Montreal scientists. Using drugs to dam this chemical reaction would condemn the disease's infectiousness.
Canadian Institutes for Health Research, National Science and Engineering Research Council of Canada

Contact: William Raillant-Clark
University of Montreal

Public Release: 7-May-2015
PLOS Pathogens
UTMB researchers devise vaccine that provides long-term protection against Chagas disease
Researchers from The University of Texas Medical Branch at Galveston have successfully tested a vaccine for Chagas disease, which is widespread in Latin America but is beginning to show up in the US -- including the Houston area.
National Institutes of Health, UTMB Sealy Center for Vaccine Development

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 7-May-2015
Malaria parasite's essential doorway into red blood cells illuminated
Researchers at Harvard T. H. Chan School of Public Health and the Broad Institute have identified a protein on the surface of human red blood cells that serves as an essential entry point for invasion by the malaria parasite.
Gates Foundation, National Institutes of Health, NIH/Eunice Kennedy Shriver National Institute of Child Health

Contact: Todd Datz
Harvard T.H. Chan School of Public Health

Public Release: 7-May-2015
World Health Assembly
The Lancet
How to build a new global health framework
Can a true, robust global health framework be created to help prevent tragedies like Ebola while at the same time allow countries to meet everyday health needs? Georgetown University global health and law experts say it can be done, and in a special issue of The Lancet focusing on global health security, they propose specific priorities to transform a fragmented health system into a 'purposeful, organized' framework with national health systems at its foundation and an empowered World Health Organization at its apex.

Contact: Karen Teber
O'Neill Institute for National and Global Health Law

Public Release: 7-May-2015
PLOS Pathogens
Chagas disease vaccine shows long-term protection in mice
Chagas disease, caused by the Trypanosoma cruzi parasite and transmitted by insects in Latin America is among the most common tropical diseases, and so far without effective vaccine. A study published on May 7 in PLOS Pathogens now shows that a candidate vaccine can induce long-lasting immunity against the parasite in mice.

Contact: Nisha J. Garg

Public Release: 6-May-2015
Show us your BabyFace: Researchers appeal for help from new parents
A new app launched by the University of Nottingham is offering parents of newborn infants the chance to play a crucial role in research that could save the lives of premature babies in the developing world.
Bill and Melinda Gates Foundation

Contact: Emma Thorne
University of Nottingham

Public Release: 6-May-2015
Social network experiments create a tipping point to improve public health
Convincing a large group of people to change its behavior is no popularity contest, a new study shows. In a novel experiment, researchers found that certain public health interventions work best when key 'influencers' in a face-to-face social network are exposed to the program. What's surprising, they say, is that those key influencers are not the most socially connected people in the network.
National Institutes of Health, Bill and Melinda Gates Foundation, Star Family Foundation, Canadian Institutes of Health Research

Contact: Jim Shelton
Yale University

Public Release: 6-May-2015
Science Translational Medicine
Mobile phone microscope rapidly detects parasite levels in blood
Scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the University of California, Berkeley, and colleagues have developed a mobile phone microscope to measure blood levels of the parasitic filarial worm Loa loa. The point-of-care device may enable safe resumption of mass drug administration campaigns to eradicate the parasitic diseases onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis).
NIH/National Institute of Allergy and Infectious Diseases

Contact: Hillary Hoffman
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 6-May-2015
Science Translational Medicine
Mobile phone video microscope automates detection of parasites in blood
A research team led by engineers at the University of California, Berkeley, has developed a new mobile phone microscope that uses video to automatically detect and quantify infection by parasitic worms in a drop of blood. This next generation of UC Berkeley's CellScope technology could help revive efforts to eradicate debilitating diseases in Africa by providing critical information for health providers in the field.
NIH/National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation, US Agency for International Development

Contact: Sarah Yang
University of California - Berkeley

Public Release: 5-May-2015
Lancet Infectious Diseases
Hepatitis C common among HIV-positive patients in sub-Saharan Africa
A new study has found high levels of infection with hepatitis C across Africa, particularly in people infected with HIV.

Contact: Sam Wong
Imperial College London

Public Release: 5-May-2015
Journal of Health, Population and Nutrition transfers to BioMed Central
The open-access Journal of Health, Population and Nutrition is now being published by BioMed Central. The journal was first published in 1983 and in transferring to the open-access publisher it joins the growing number of global health journals within the portfolio.

Contact: Shane Canning
BioMed Central

Public Release: 4-May-2015
Journal of Experimental Medicine
Malarial parasites dodge the kill
Scientists have uncovered a potential mode of parasite drug resistance in malaria infection, opening new opportunities for the design of anti-malarial drugs.
European Community's Seventh Framework Programme, Agency for Innovation by Science and Technology (IWT), Geconcerteerde OnderzoeksActies, Research Fund of the KU Leuven, Fund for Scientific Research, Medical Research Council

Contact: Rita Sullivan King
Rockefeller University Press

Public Release: 30-Apr-2015
GHIT Fund boosts anti-malarial drug research at Griffith University
At Griffith University's world-leading Eskitis Institute for Drug Discovery, support from the powerful Global Health Innovative Technology Fund is helping Professor Vicky Avery and her team in the fight against malaria.
Global Health Innovative Technology Fund

Contact: Michael Jacobson
Griffith University

Public Release: 30-Apr-2015
PLOS Computational Biology
Optimizing treatment protocols when diagnostics are costly
HIV-1 continues to spread globally. While neither a cure, nor an effective vaccine are available, recent focus has been put on 'treatment-for-prevention', which is a method by which treatment is used to reduce the contagiousness of an infected person. A study published this week in PLOS Computational Biology challenges current treatment paradigms in the context of 'treatment for prevention' against HIV-1.

Contact: Max von Kleist

Showing releases 601-625 out of 1221.

<< < 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 > >>